Small molecule Plasmodium FKBP35 inhibitor as a potential antimalaria agent

Malaria parasite strains have emerged to tolerate the therapeutic effects of the prophylactics and drugs presently available. This resistance now poses a serious challenge to researchers in the bid to overcome malaria parasitic infection. Recent studies have shown that FK520 and its analogs inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Harikishore, Amaravadhi, Niang, Makhtar, Rajan, Sreekanth, Preiser, Peter Rainer, Yoon, Ho Sup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752609/
https://www.ncbi.nlm.nih.gov/pubmed/23974147
http://dx.doi.org/10.1038/srep02501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752609/
https://www.ncbi.nlm.nih.gov/pubmed/23974147
http://dx.doi.org/10.1038/srep02501

Ejemplares similares